These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 2966629)

  • 1. Immunopharmacological actions of the new antiallergic drug butyl 3'-(1H-tetrazol-5-yl)oxanilate. 1st communication: effects on type I to type IV allergic reactions in animal models.
    Yanagihara Y; Abe T; Edanami K; Agata M; Kuroda T; Shida T
    Arzneimittelforschung; 1988 Jan; 38(1):70-4. PubMed ID: 2966629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunopharmacological actions of the new antiallergic drug butyl 3'-(1H-tetrazol-5-yl)oxanilate. 3rd communication: inhibitory effects on histamine release from lung fragments, Schultz-Dale reaction in isolated tracheal muscle and experimental asthma in guinea pigs.
    Yanagihara Y; Abe T; Kuroda T; Shida T
    Arzneimittelforschung; 1988 Jan; 38(1):80-3. PubMed ID: 2452640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunopharmacological actions of the new antiallergic drug butyl 3'-(1H-tetrazol-5-yl)oxanilate. 5th communication: effects on immunological reactions in mice and humans.
    Yanagihara Y; Abe T; Kuroda T; Shida T
    Arzneimittelforschung; 1988 Jan; 38(1):88-92. PubMed ID: 3365280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunopharmacological actions of the new antiallergic drug butyl 3'-(1H-tetrazol-5-yl)oxanilate. 2nd communication: inhibitory effects on histamine release from rat mast cells and lung fragments.
    Yanagihara Y; Abe T; Kuroda T; Shida T
    Arzneimittelforschung; 1988 Jan; 38(1):75-9. PubMed ID: 2452639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-allergic effects of tazanolast [butyl 3'-(1H-tetrazol-5-yl) oxanilate, WP-833] metabolites].
    Hashimoto T; Edanami K; Naito A; Sano K; Fushimi H; Goto M
    Nihon Yakurigaku Zasshi; 1990 Apr; 95(4):159-66. PubMed ID: 1695192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunopharmacological actions of the new antiallergic drug butyl 3'-(1H-tetrazol-5-yl)oxanilate. 4th communication: effects on histamine release from human leukocytes and from human and monkey lung fragments.
    Yanagihara Y; Abe T; Tsuriya Y; Kuroda T; Shida T
    Arzneimittelforschung; 1988 Jan; 38(1):84-7. PubMed ID: 2452641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-allergic effects of ketanserin on animal models of allergic reactions.
    Nagai H; Suda H; Kitagaki K; Goto S; Miura T; Koda A
    Arch Int Pharmacodyn Ther; 1990; 307():172-82. PubMed ID: 1710442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of KC-404 on allergic reactions types I-IV].
    Nishino K; Hara S; Irikura T
    Nihon Yakurigaku Zasshi; 1984 Apr; 83(4):291-9. PubMed ID: 6235160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunopharmacological studies on TBX, a new antiallergic drug (1). Inhibitory effects on passive cutaneous anaphylaxis in rats and guinea pigs.
    Yanagihara Y; Kasai H; Kawashima T; Shida T
    Jpn J Pharmacol; 1988 Sep; 48(1):91-101. PubMed ID: 2462074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiallergic properties of an orally effective agent, [[3-(1H-tetrazol-5-yl)-phenyl] amino] oxoacetic acid n-butyl ester.
    Agata M; Goto H; Tsuriya Y; Tachibana K; Kuroda T
    Jpn J Pharmacol; 1982 Aug; 32(4):689-97. PubMed ID: 6182323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of ferulic acid on allergic reaction].
    Hu HJ; Hang BQ
    Zhongguo Yao Li Xue Bao; 1991 Sep; 12(5):426-30. PubMed ID: 1840284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunopharmacological studies on TBX, a new antiallergic drug (4). Effects on type II to IV allergic reactions and immunological functions in animal models.
    Yanagihara Y; Kasai H; Kawashima T; Ninomiya K
    Jpn J Pharmacol; 1989 Sep; 51(1):93-100. PubMed ID: 2530379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of SA-103 on experimental allergic models in vivo and in vitro--comparison with disodium cromoglycate.
    Nabe T; Yamamura H; Kohno S; Ohata K
    Arerugi; 1992 Jun; 41(6):676-85. PubMed ID: 1280084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [[Effect of traxanox sodium on type I-IV allergic reactions. Studies on anti-allergic agents VII].
    Terasawa M; Goto K; Maruyama Y
    Nihon Yakurigaku Zasshi; 1982 Dec; 80(6):417-27. PubMed ID: 6219052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the new antiallergic drug 11-oxo-11H-pyrido[2,1-b] quinazoline-2-carboxylic acid on immediate allergic reactions.
    Koda A; Nagai H; Mori H; Inagaki N; Nishiyori T; Matsuura N; Iwamoto T; Furukawa K; Yamada H; Goto S
    Arzneimittelforschung; 1986 Nov; 36(11):1609-18. PubMed ID: 2434109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute effects of deflazacort and its metabolite 21-desacetyl-deflazacort on allergic reactions.
    Omote M; Sakai K; Mizusawa H
    Arzneimittelforschung; 1994 Feb; 44(2):149-53. PubMed ID: 7511903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of epinastine on the type II-IV allergic reactions in mice, rats and guinea pigs.
    Kamei C; Izushi K; Adachi Y; Shimazawa M; Tasaka K
    Arzneimittelforschung; 1991 Nov; 41(11):1150-3. PubMed ID: 1687348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiallergic effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidaz ole difumarate (KB-2413).
    Fukuda T; Saito T; Tajima S; Shimohara K; Ito K
    Arzneimittelforschung; 1984; 34(7):805-10. PubMed ID: 6208915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological studies of N-(2-mercapto-2-methylpropanoyl)-L-cysteine (SA96) (3). Effects of SA96 on experimental allergic reactions.
    Nakata K; Suda H; Yamauchi H; Iso T
    Jpn J Pharmacol; 1985 Jan; 37(1):83-90. PubMed ID: 3157817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent inhibitory activity of HSR-6071, a new antiallergic agent, on passive cutaneous anaphylaxis (PCA).
    Makino E; Ohashi T; Takahashi H; Kato H; Ito Y; Nagai H; Koda A; Azuma H
    Jpn J Pharmacol; 1990 Jan; 52(1):87-94. PubMed ID: 1689783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.